Facebook
Twitter
Telegram
Report an ErrorOutlook Therapeutics Financial Statements 2011-2024 | OTLK
Annual Financial Statements Outlook Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
105 M | 231 M | 153 M | 56.6 M | 22.1 M | 35.5 M | 32.2 M | 72 M | - | - | - | - | - |
Shares |
250 M | 212 M | 153 M | 72.6 M | 18.2 M | 4.93 M | 3 M | 2.15 M | - | - | - | - | - |
Historical Prices |
0.42 | 1.09 | 1.63 | 2.17 | 0.76 | 8.88 | 9.12 | 25.5 | - | - | - | - | - |
Net Income |
-59 M | -66.1 M | -53.2 M | -35.2 M | -34.5 M | -30.1 M | -38.8 M | -53.3 M | -47.4 M | -13.7 M | - | - | - |
Revenue |
- | - | -46.3 K | - | 8.15 M | 3.09 M | 3.81 M | 2.98 M | 5.22 M | 9.05 M | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-53.1 M | -63.1 M | -51.7 M | -36.8 M | -36.3 M | -29.6 M | -35.9 M | -51.3 M | -46.6 M | - | - | - | - |
Interest Expense |
-1.56 M | -1.49 M | -936 K | 1.76 M | 3.47 M | 3.89 M | 5.63 M | 1.47 M | 2.3 M | - | - | - | - |
EBITDA |
-53.1 M | -62.9 M | -51.5 M | -35.8 M | -21.7 M | -26.6 M | -33.2 M | -49.4 M | -44.7 M | -11.5 M | - | - | - |
Operating Expenses |
- | - | - | 36.3 M | 33.2 M | 32.7 M | 39.7 M | 54.7 M | - | - | - | - | - |
General and Administrative Expenses |
26.7 M | 20.7 M | 12.8 M | 9.97 M | 9.37 M | 14.2 M | 15.9 M | 21.6 M | 12.9 M | 7.32 M | - | - | - |
All numbers in USD currency
Quarterly Income Statement Outlook Therapeutics
| 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
260 M | 260 M | 257 M | 257 M | 227 M | 227 M | 220 M | 219 M | 188 M | 147 M | 168 M | 151 M | 122 M | 56.1 M | 90.8 M | 47.9 M | 29.9 M | 14.8 M | 23 M | 29.9 M | 9.84 M | 3.55 M | 34.5 M | 25.7 M | 25 M | 23.8 M | 24.4 M | 23.7 M | 23.2 M | 15.3 M | 18.8 M | 14.2 M | 13.1 M | 9.45 M | 9.59 M | 9.38 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-11.2 M | - | -20.7 M | -6.65 M | -18.7 M | -51.7 M | -17.5 M | -19.7 M | -14.5 M | -39.8 M | -12.2 M | -13.1 M | -14.5 M | -25.3 M | -3.01 M | -14.5 M | -16.6 M | -24.4 M | -4.44 M | -16.6 M | -9.74 M | -17.9 M | -8.43 M | -9.74 M | -1.92 M | -32.5 M | -5.33 M | -1.92 M | -19.1 M | -42.7 M | -22.3 M | -19.1 M | -16.9 M | -30.2 M | -11.3 M | -14 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | 21.5 K | -41.5 K | -11.8 K | -6.04 K | -23.7 K | -435 K | -435 K | - | - | - | - | - | - | 2.29 M | 584 K | 641 K | 1.07 M | 2.32 M | 772 K | 1.07 M | 772 K | 909 K | 303 K | 772 K | 303 K | 2.48 M | 495 K | 303 K | 995 K | 4.72 M | 1.29 M | 495 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-10.3 M | - | -18.1 M | -6.84 M | -15.7 M | -49.1 M | -17 M | -18.9 M | -13.1 M | -38.3 M | -11.5 M | -12.6 M | -14.2 M | -26.8 M | -11.9 M | -14.2 M | -8.18 M | -23.6 M | -5.64 M | -8.18 M | -10.3 M | -17.2 M | -7.22 M | -10.3 M | -3.18 M | -33 M | -7.34 M | -3.18 M | -17.8 M | -41.4 M | -22 M | -17.9 M | -16.4 M | -29.2 M | -11 M | -14 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
189 K | - | 395 K | 188 K | -2.45 M | -1.13 M | -357 K | -418 K | -352 K | -667 K | -257 K | 250 K | 160 K | -1.74 M | 444 K | 696 K | 598 K | 3.26 M | 1.08 M | 598 K | 1.12 M | 2.79 M | 1.15 M | 1.12 M | 718 K | 3.48 M | 1.75 M | 718 K | 489 K | 1.24 M | 299 K | 387 K | 399 K | 1.62 M | 555 K | 706 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-10.3 M | - | - | - | -15.7 M | -48.9 M | -17 M | -18.9 M | -13.1 M | -38.1 M | -11.4 M | -12.6 M | -14.1 M | -26.4 M | -11.8 M | -14.1 M | -8.12 M | -21.1 M | -4.81 M | -7.37 M | -9.43 M | -15 M | -6.4 M | -9.43 M | -2.5 M | -30.9 M | -6.66 M | -2.5 M | -17.1 M | -39.6 M | -21.4 M | -17.2 M | -15.8 M | -28.3 M | -10.6 M | -13.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | 11.5 M | 12.6 M | 14.2 M | 26.8 M | 11.9 M | 6.76 M | 8.18 M | 25.9 M | 6.23 M | 8.18 M | 11.3 M | 19.5 M | 7.99 M | 11.3 M | 3.95 M | 33.9 M | 7.64 M | 3.95 M | 18.1 M | 43.9 M | 22.5 M | 18.2 M | 17.4 M | 33.9 M | 12.3 M | 14.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
5.79 M | - | 7.04 M | 6.29 M | 5.83 M | 15.7 M | 5.77 M | 6.69 M | 3.28 M | 9.27 M | 2.93 M | 4.1 M | 2.24 M | 7.58 M | 3.29 M | 2.24 M | 2.34 M | 6.59 M | 1.83 M | 2.34 M | 2.9 M | 8.19 M | 2.2 M | 2.9 M | 3.55 M | 12.4 M | 3.48 M | 3.55 M | 4.87 M | 15 M | 10.5 M | 4.89 M | 4.67 M | 8.24 M | 2.66 M | 4.34 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency